News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News Understanding How Flu Viruses Affect the Heart Could Boost COVID-19 Care Caitlin E. Cox October 05, 2020
News Daily News More Insights Into AAA Genetics Spur New Questions on Screening Caitlin E. Cox September 29, 2020
News Daily News Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies Caitlin E. Cox September 18, 2020
News Conference News ESC 2020 EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression Yael L. Maxwell September 02, 2020
News Daily News US Mortality Rates for CVD Have Stalled as Racial Disparities Widen Yael L. Maxwell August 19, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Had COVID-19? ‘Hidden’ CV Damage Warrants Cautious Return to Physical Activity Michael O'Riordan June 17, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Conference News ACC 2020 Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH Yael L. Maxwell April 06, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 Evinacumab Cuts LDL Cholesterol in Homozygous FH Yael L. Maxwell April 01, 2020
News Daily News Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link Yael L. Maxwell January 13, 2020